A leading international biotech company wanted an adaptive platform which would provide a real-time depiction of the company’s financials based on the performance of 30+ product-indication combinations having a market worth of around $2B.

Viscadia was asked to design and build a scalable and dynamic long-range planning model which would aggregate the product and firm level financials from cross-functional stakeholders in order to create an all – encompassing portfolio dashboard.